News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
200 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26720)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (3)
2 (179)
3 (245)
4 (202)
5 (200)
6 (79)
7 (2)
8 (4)
9 (110)
10 (192)
11 (196)
12 (192)
13 (100)
14 (12)
15 (19)
16 (207)
17 (196)
18 (165)
19 (172)
20 (82)
21 (16)
22 (25)
23 (174)
24 (236)
25 (208)
26 (217)
27 (73)
30 (213)
31 (258)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
30
31
Vivoryon Therapeutics N.V. Announces Virtual R&D Event with Key Opinion Leaders and Upcoming Conference Participation
Vivoryon Therapeutics N.V. announced its plans to host a Virtual R&D Event with Key Opinion Leaders on October 17, 2023.
October 5, 2023
·
3 min read
Angany announces First-in-Human Clinical Study on ANG-101, a Vaccine Candidate to Treat Cat Allergy
Angany Inc., announces that it has received clearance (Notice of Acceptance) from MHRA (Medicines and Healthcare Products Regulatory Agency) for the first clinical study to be conducted on its vaccine candidate ANG-101 to treat human allergy to cats.
October 5, 2023
·
3 min read
Business
RUBY KAM JOINS BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AS CHIEF FINANCIAL OFFICER
Ruby Kam has joined Blue Cross Blue Shield of Massachusetts (“Blue Cross”) as chief financial officer.
October 5, 2023
·
1 min read
Business
Promontory Therapeutics Announces Early Phase 2 Clinical Trial Data From the National Cancer Institute, Demonstrating PT-112’s Immune Activation in Thymic Epithelial Tumors
The National Cancer Institute today presented preliminary results from the Phase 2 clinical trial of Promontory’s lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumors (TETs).
October 5, 2023
·
5 min read
BioMidwest
Discovery Life Sciences expands high-throughput proteomics services
Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced it has expanded its high-throughput proteomics services with the addition of Olink Explore HT.
October 5, 2023
·
3 min read
Deals
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
AbbVie (NYSE: ABBV) announced today that it has exercised its exclusive right and completed the acquisition of Mitokinin, a discovery-stage biotechnology company developing a potentially first-in-class disease-modifying treatment for Parkinson’s Disease (PD).
October 5, 2023
·
4 min read
Business
FROEDTERT HEALTH, WISCONSIN DIAGNOSTIC LABORATORIES AND HEALTHECO LAUNCH ATALAN, A TECHNOLOGY-ENABLED CLINICAL PARTNERSHIP PROVIDING ACCESS TO THE BEST IN LABORATORY MEDICINE
Froedtert Health, Wisconsin Diagnostic Laboratories (WDL) and HealthEco announced today the launch of Atalan , a technology-enabled clinical partnership providing doctors and medical centers unprecedented access to a vetted network of the nation’s foremost clinical laboratories.
October 5, 2023
·
3 min read
Business
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform
Aditxt, Inc. announced today that it has appointed Ernie Lee to serve as the Chief Executive Officer of the Company’s wholly-owned subsidiary Pearsanta, Inc. (“Pearsanta”).
October 5, 2023
·
5 min read
Drug Development
RG6501 (OpRegen®) Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Lineage Cell Therapeutics, Inc. today announced that the results of imaging analyses demonstrating rapid improvement in outer retinal structure from patients enrolled in a Phase 1/2a clinical study of RG6501 (OpRegen) (ClinicalTrials.gov Identifier: NCT02286089), which were reviewed by multiple, independent reviewers, were presented at the 23rd EURETINA Congress.
October 5, 2023
·
9 min read
Business
Dermavant Appoints John Darden as New Head of Marketing
Dermavant Sciences today announced the appointment of John Darden as Vice President of Marketing. Darden brings more than 15 years of sales, marketing and market access experience in dermatology and immunology.
October 5, 2023
·
3 min read
Previous
14 of 20
Next